Granite Harbor Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
3,887
+217
+6% +$12.5K 0.09% 122
2026
Q1
$223K Buy
+3,670
New +$214K 0.1% 119

Other funds holding BMY

Granite Harbor Advisors's BMY Position: Q2 2026 in Review

Granite Harbor Advisors increased its Bristol-Myers Squibb (BMY) stake by 5.9% in Q2 2026, buying an estimated $12.5K and bringing the position to 3,887 shares worth $224K. The position accounts for 0.09% of the portfolio, ranked #122.

Granite Harbor Advisors first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Granite Harbor Advisors held 3,887 shares of Bristol-Myers Squibb worth $224K as of Q2 2026.
  • Granite Harbor Advisors bought 217 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.5K.
  • Bristol-Myers Squibb made up 0.09% of Granite Harbor Advisors's portfolio in Q2 2026, its #122 holding.
  • Granite Harbor Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Granite Harbor Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.